alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Term ID

CHEBI:28424

Synonyms

(2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyra
(Gal)1 (Glc)1 (Neu5Ac)2 (Cer)1
(Neu5Ac)GD3
alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
alpha-N-acetylneuraminosyl-(2->8)-alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramides
alpha-N-Acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-glucosyl-1,1'-ceramide
alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
CD60a
disialoganglioside GD3
Ganglioside GD3
GD3
GD3 ganglioside
Neu5Acalpha2->8Neu5Acalpha2->3Galbeta1->4Glcbeta1->1Cer
NeuAc(alpha2-8)NeuAc(alpha2-3)Gal(beta1-4)Glc(beta1-1)Cer
NeuAc-alpha2->8NeuAc-alpha2->3Gal-beta1->4Glc-beta1->1'Cer
NeuAc-alpha2->8NeuAc2->3Gal-beta1->4Glc-beta1->1'Cer
NeuAc-alpha2->8NeuAc2->3LacCer
NeuAc2-GD3
NeuAcalpha2-8NeuAcalpha2-3Galbeta1-4Glcbeta1-1'Cer

Definition

A sialodiosylceramide consisting of the tetrasaccharide α-Neu5NAc-(2→8)-α-Neu5NAc-(2→3)-β-D-Gal-(1→4)-β-D-Glc attached to the primary hydroxy function of ceramide.

References

kegg.compound:C06133
kegg.glycan:G00113
pubmed:12019315
pubmed:12032669
pubmed:12058281
pubmed:12770783
pubmed:12950986
pubmed:1371229
pubmed:15207324
pubmed:15896784
pubmed:16081368
pubmed:16341241
pubmed:16434401
pubmed:17043769
pubmed:1724444
pubmed:17855742
pubmed:19726417
pubmed:21149694
pubmed:21376640
pubmed:2303428
pubmed:2448252
pubmed:25748038
pubmed:2604027
pubmed:28424
pubmed:3292056
pubmed:3742610
pubmed:6204642
pubmed:6206564
pubmed:6362854
pubmed:7534889
pubmed:7691279
pubmed:7693874
pubmed:8448384

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype where environments contain alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype modified by environments containing alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Phenotype affecting alpha-Neu5NAc-(2->8)-alpha-Neu5NAc-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Human Disease Model